Page last updated: 2024-09-03

gefitinib and 2-piperidone

gefitinib has been researched along with 2-piperidone in 1 studies

Compound Research Comparison

Studies (gefitinib)	Trials (gefitinib)	Recent Studies (post-2010) (gefitinib)	Studies (2-piperidone)	Trials (2-piperidone)	Recent Studies (post-2010) (2-piperidone)
5,231	566	2,919	1,305	65	594

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bergqvist, M; Bergström, S; Ekman, S; Gullbo, J; Lennartsson, J; Sooman, L	1

Other Studies

1 other study(ies) available for gefitinib and 2-piperidone

Article	Year
Synergistic effects of combining proteasome inhibitors with chemotherapeutic drugs in lung cancer cells. BMC research notes, 2017, Nov-02, Volume: 10, Issue:1 Topics: Adenocarcinoma; Antineoplastic Agents; Bortezomib; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Deoxycytidine; Drug Therapy, Combination; Gefitinib; Gemcitabine; Humans; Piperidones; Proteasome Inhibitors; Quinazolines; Small Cell Lung Carcinoma; Vinblastine; Vinorelbine	2017

Article

Year

Synergistic effects of combining proteasome inhibitors with chemotherapeutic drugs in lung cancer cells.

BMC research notes, 2017, Nov-02, Volume: 10, Issue:1

Topics: Adenocarcinoma; Antineoplastic Agents; Bortezomib; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Deoxycytidine; Drug Therapy, Combination; Gefitinib; Gemcitabine; Humans; Piperidones; Proteasome Inhibitors; Quinazolines; Small Cell Lung Carcinoma; Vinblastine; Vinorelbine

2017